M Isabel S Dinelli1, Erika Ono1, Patrícia O Viana1, Amélia M N Dos Santos2, M Isabel de Moraes-Pinto3. 1. Division of Pediatric Infectious Diseases, Department of Pediatrics, Federal University of São Paulo, Rua Pedro de Toledo, 781/9°andar, São Paulo, SP, 04039-032, Brazil. 2. Division of Neonatal Medicine, Department of Pediatrics, Federal University of São Paulo, São Paulo, Brazil. 3. Division of Pediatric Infectious Diseases, Department of Pediatrics, Federal University of São Paulo, Rua Pedro de Toledo, 781/9°andar, São Paulo, SP, 04039-032, Brazil. m.isabelmp@uol.com.br.
Abstract
Neonates born to transplanted mothers are exposed to immunosuppressive drugs during gestation and have a higher risk of being born prematurely and small for gestational age than the general population. We have prospectively followed up 27 children born to renal transplanted mothers from a single center and 31 healthy children born at term with adequate weight for gestational age. Comparisons of weight and length measurements were made at birth, 1 month (±0.9), 3 months (±1.0), 6 months (±1.0), 9 months (±1.5), and 12 months (±1.49) of age. There were a high rate of prematurity (51.9%) and neonates small for gestational age (40.7%) in the transplant group. At birth, in the transplant group, 28% of neonates had subnormal z-scores for weight and 40%, low z-scores for length. However, at 6 months of age, no significant differences were noticed in mean weight-for-age z-scores between groups (weight -0.43 vs -0.03; length -0.53 vs -0.08). At 12 months of age, comparable mean length-for-age z-scores were observed in both groups (weight 0.01 vs 0.27; length -0.07 vs 0.26). CONCLUSION: Despite high rates of premature births and neonates small for gestational age in the transplant group, there was a good recovery of growth during the first year.. What is Known: • Children born to renal transplanted mothers are exposed to immunosuppressive drugs during gestation [4]. • They have high risk of premature birth and fetal growth restriction, immune alterations at birth, and risk of hospitalization for infection in the first months of life [5]. What is New: • Despite high rates of premature birth and neonates small for gestational age, these infants had good growth recovery by 1 year of age.
Neonates born to transplanted mothers are exposed to immunosuppressive drugs during gestation and have a higher risk of being born prematurely and small for gestational age than the general population. We have prospectively followed up 27 children born to renal transplanted mothers from a single center and 31 healthy children born at term with adequate weight for gestational age. Comparisons of weight and length measurements were made at birth, 1 month (±0.9), 3 months (±1.0), 6 months (±1.0), 9 months (±1.5), and 12 months (±1.49) of age. There were a high rate of prematurity (51.9%) and neonates small for gestational age (40.7%) in the transplant group. At birth, in the transplant group, 28% of neonates had subnormal z-scores for weight and 40%, low z-scores for length. However, at 6 months of age, no significant differences were noticed in mean weight-for-age z-scores between groups (weight -0.43 vs -0.03; length -0.53 vs -0.08). At 12 months of age, comparable mean length-for-age z-scores were observed in both groups (weight 0.01 vs 0.27; length -0.07 vs 0.26). CONCLUSION: Despite high rates of premature births and neonates small for gestational age in the transplant group, there was a good recovery of growth during the first year.. What is Known: • Children born to renal transplanted mothers are exposed to immunosuppressive drugs during gestation [4]. • They have high risk of premature birth and fetal growth restriction, immune alterations at birth, and risk of hospitalization for infection in the first months of life [5]. What is New: • Despite high rates of premature birth and neonates small for gestational age, these infants had good growth recovery by 1 year of age.
Authors: Lisa A Coscia; Serban Constantinescu; Michael J Moritz; John S Radomski; William J Gaughan; Carolyn H McGrory; Vincent T Armenti Journal: Clin Transpl Date: 2007
Authors: Kimmie K McLaurin; Caroline B Hall; E Anne Jackson; Oksana V Owens; Parthiv J Mahadevia Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: Melanie L Wyld; Philip A Clayton; Sean E Kennedy; Stephen I Alexander; Steven J Chadban Journal: JAMA Pediatr Date: 2015-02-02 Impact factor: 16.193
Authors: Lisa A Coscia; Serban Constantinescu; Michael J Moritz; Adam M Frank; Carlo B Ramirez; Warren R Maley; Cataldo Doria; Carolyn H McGrory; Vincent T Armenti Journal: Clin Transpl Date: 2010
Authors: F R Willis; C A Findlay; M J Gorrie; M A Watson; A G Wilkinson; T J Beattie Journal: J Paediatr Child Health Date: 2000-06 Impact factor: 1.954
Authors: T Mac Bird; Janet M Bronstein; Richard W Hall; Curtis L Lowery; Richard Nugent; Glen P Mays Journal: Pediatrics Date: 2010-07-05 Impact factor: 7.124
Authors: Fernando C Barros; José Luis Diaz Rossello; Alicia Matijasevich; Samuel C Dumith; Aluisio J D Barros; Iná Silva dos Santos; Denise Mota; Cesar G Victora Journal: BMC Pediatr Date: 2012-10-31 Impact factor: 2.125
Authors: Cameron J McKinzie; Jillian P Casale; Jack C Guerci; Alyson Prom; Christina T Doligalski Journal: Paediatr Drugs Date: 2022-07-23 Impact factor: 3.930